![]() |
![]() |
Ginsenoside Rg1 is one of the major active components of ginseng. Ginsenoside Rg1 displays promising effects by reducing cerebral Aβ levels. Ginsenoside Rg1 also reduces NF-κB nuclear translocation.
Ginsenoside Rg1 is a ginsenoside found in Panax ginseng and Panax japonicus var. major that is dammarane which is substituted by hydroxy groups at the 3beta, 6alpha, 12beta and 20 pro-S positions, in which the hydroxy groups at positions 6 and 20 have been converted to the corresponding beta-D-glucopyranosides, and in which a double bond has been introduced at the 24-25 position. It has a role as a neuroprotective agent and a pro-angiogenic agent. It is a 12beta-hydroxy steroid, a beta-D-glucoside, a tetracyclic triterpenoid, a ginsenoside and a 3beta-hydroxy-4,4-dimethylsteroid. It derives from a hydride of a dammarane.|Ginsenosides are a class of steroid glycosides, and triterpene saponins, found exclusively in the plant genus Panax (ginseng). Ginsenosides have been the target of research, as they are viewed as the active compounds behind the claims of ginseng's efficacy. Because ginsenosides appear to affect multiple pathways, their effects are complex and difficult to isolate. Rg1 Appears to be most abundant in Panax ginseng (Chinese/Korean Ginseng). It improves spatial learning and increase hippocampal synaptophysin level in mice, plus demonstrates estrogen-like activity.
View more+(3α,5ξ,8α,9ξ,10α,12α,13α,14ξ,17α,20R)-3,12,25-Trihydroxy-20,24-epoxydammaran-6-yl 2-O-(6-deoxyhexopyranosyl)hexopyranoside - (3α,5ξ,8α,9ξ,10α,12α,13α,1 (3β,5ξ,6α,13α,14β)-20-(β-D-Glucopyranosyloxy)-3,12-dihydroxydammar-24-en-6-yl β-D-glucopyranoside (3β,6α,12β)-3,12-Dihydroxydammar-24-ene-6,20-diyl bis-β-D-glucopyranoside ,9ξ,10α,12α,13α,14ξ,17ξ,20ξ)-20-(hexopyranosyloxy)-3,12-dihydroxydammar-24-en-6-yl (1:1) 20-(Hexopyranosyloxy)-3,12-dihydroxydammar-24-en-6-yl hexopyranoside 4ξ,17ξ,20ξ)-20-(hexopyranosyloxy)-3,12-dihydroxydammar-24-en-6-yl hexopyranoside (1:1) Ginsenoside A2 Ginsenoside g1 Ginsenoside Rg1 mixture with ginsenoside A1 Ginsenosideg1 GinsenosideRg1 (8CI) Hexopyranoside, (3α,5ξ,8α,9ξ,10α,12α,13α,14ξ,17α,20R)-20,24-epoxy-3,12,25-trihydroxydammaran-6-yl 2-O-(6-deoxyhexopyranosyl)-, compd. with hexopyranoside, (3α,5ξ,8α Hexopyranoside, 20-(hexopyranosyloxy)-3,12-dihydroxydammar-24-en-6-yl Panaxoside A Panaxoside A (7CI) Panaxoside Rg1 Panaxsaponin Rg1 Rg1 ginsenoside Sanchinoside C1 Sanchinoside Rg1 β-D-Glucopyranoside, (3β,5ξ,6α,13α,14β)-20-(β-D-glucopyranosyloxy)-3,12-dihydroxydammar-24-en-6-yl β-D-Glucopyranoside, (3β,6α,12β)-3,12-dihydroxydammar-24-ene-6,20-diyl bis-
Acute toxicity - Oral, Category 4
Pictogram(s) | ![]() |
---|---|
Signal word | Warning |
Hazard statement(s) | H302 Harmful if swallowed |
Precautionary statement(s) | |
Prevention | P264 Wash ... thoroughly after handling. P270 Do not eat, drink or smoke when using this product. |
Response | P301+P312 IF SWALLOWED: Call a POISON CENTER/doctor/\u2026if you feel unwell. P330 Rinse mouth. |
Storage | none |
Disposal | P501 Dispose of contents/container to ... |
none
![]() |
![]() |
![]() |
![]() |